Publication: 3170

Publication: 3170

A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Support Care Cancer vol 29 (1) 387-96

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 10

Parents:: 2972
Children:: None

Program:: CCP
Primary Committee:: Symptom Inter
Sec. Committees:: Health Outcomes

Pharmas:
Grants:: UG1CA189823; U24CA196171, UG1CA232760; UG1CA189858, UG1CA189997; U10CA180820, UG1CA189861 (ECOG-ACRIN); U10CA180868 (NRG)

Corr. Author:
Authors:: Elizabeth Cathcart-Rake Paul Novotny Roberto Leon-Ferre Jennifer Le-Rademacher Elizabeth M. Storrick Araba A. Adjei Shelby Terstriep Rebecca Glaser Armando Giuliano William R. Mitchell Seth Page Colleen Austin Richard L. Deming Margaret A. Ferreira Jacqueline M. Lafky Stephen N. Birrell Charles L. Loprinzi

Networks:: CA016, DAYTON, IWORC, KS055, LAPS-MN026, SANFORD, SCOR

Study: Alliance-A221102
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: